These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8974456)

  • 1. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
    Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
    Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
    Bongartz JP; Aubertin AM; Milhaud PG; Lebleu B
    Nucleic Acids Res; 1994 Nov; 22(22):4681-8. PubMed ID: 7984418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
    Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
    Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes.
    Zelphati O; Wagner E; Leserman L
    Antiviral Res; 1994 Sep; 25(1):13-25. PubMed ID: 7811058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif.
    Pichon C; Arar K; Stewart AJ; Dodon MD; Gazzolo L; Courtoy PJ; Mayer R; Monsigny M; Roche AC
    Mol Pharmacol; 1997 Mar; 51(3):431-8. PubMed ID: 9058598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity.
    Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
    Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides.
    Soukchareun S; Tregear GW; Haralambidis J
    Bioconjug Chem; 1995; 6(1):43-53. PubMed ID: 7711103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents.
    Morvan F; Porumb H; Degols G; Lefebvre I; Pompon A; Sproat BS; Rayner B; Malvy C; Lebleu B; Imbach JL
    J Med Chem; 1993 Jan; 36(2):280-7. PubMed ID: 8423598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.
    Tang JY; Temsamani J; Agrawal S
    Nucleic Acids Res; 1993 Jun; 21(11):2729-35. PubMed ID: 8392706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N alpha-(tert-butoxycarbonyl)-N epsilon-[N-(bromoacetyl)-beta-alanyl]-L-lysine: its use in peptide synthesis for placing a bromoacetyl cross-linking function at any desired sequence position.
    Inman JK; Highet PF; Kolodny N; Robey FA
    Bioconjug Chem; 1991; 2(6):458-63. PubMed ID: 1805944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.
    Bonfils E; Depierreux C; Midoux P; Thuong NT; Monsigny M; Roche AC
    Nucleic Acids Res; 1992 Sep; 20(17):4621-9. PubMed ID: 1408764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.
    Astriab-Fisher A; Sergueev DS; Fisher M; Shaw BR; Juliano RL
    Biochem Pharmacol; 2000 Jul; 60(1):83-90. PubMed ID: 10807948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach.
    Sumbatyan NV; Mandrugin VA; Deroussent A; Bertrand JR; Majer Z; Malvy C; Korshunova GA; Hollosi M; Gottikh MB
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1911-27. PubMed ID: 15628748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
    Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
    Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
    Zatsepin TS; Turner JJ; Oretskaya TS; Gait MJ
    Curr Pharm Des; 2005; 11(28):3639-54. PubMed ID: 16305500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
    Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
    Wang C; Shi W; Cai L; Lu L; Yu F; Wang Q; Jiang X; Xu X; Wang K; Xu L; Jiang S; Liu K
    J Antimicrob Chemother; 2014 Jun; 69(6):1537-45. PubMed ID: 24500189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.